12th April 2022 | Pharma Updates
IIT Madras introduces India's first polycentric prosthetic knee produced in-house
Researchers at the Indian Institute of Technology Madras have built India’s first polycentric prosthetic knee, with the goal of improving the quality of life for thousands of above-knee amputees.
INSACOG lab testing in India to validate XE strain
A federal government laboratory affiliated with INSACOG, a pan-India consortium of 38 labs entrusted with monitoring genetic alterations in SARS-CoV-2, is undertaking additional tests to establish the presence of the XE variant in India.
Glenmark's new chemical GRC 54276 has been approved for a Phase 1 clinical trial by DCGI
Glenmark Specialty has got authorisation from the Indian drug authority, DCGI, to undertake a Phase 1 clinical trial of GRC 54276, a hematopoietic progenitor kinase 1 (HPK1) inhibitor.
Arachitol gummies are now available in India from Abbott
Abbott announced on Monday the launch of Arachitol Gummies in India, a dietary supplement that helps sustainably maintain needed amounts of Vitamin D.
MedGenome introduces VarMiner, a tool for identifying genetic variants
VarMiner, an AI-enabled sophisticated variant interpretation software suite, has been created and released by MedGenome Labs to interpret and report actionable mutations thanks to the proprietary software.
Sanolla receives FDA Approval for the World's First AI-Powered Infrared Stethoscope
Sanolla has received FDA 510(k) clearance for the clinical use of its device VoqX, the first and only stethoscope that can listen to infrasound, acoustic sound waves that the human ear cannot detect.
Veru's novel COVID-19 drug candidate reduces deaths in hospitalised patients by 55%
Veru disclosed favourable efficacy and safety data from a planned interim analysis of the Phase 3 COVID-19 clinical study for Acute Respiratory Distress Syndrome (ARDS).
